Mitotane is an adrenolytic agent primarily indicated for the treatment of adrenocortical carcinoma and hormone excess associated with Cushing's syndrome, functioning by selectively destroying cells within… Read more
Mitotane is an adrenolytic agent primarily indicated for the treatment of adrenocortical carcinoma and hormone excess associated with Cushing's syndrome, functioning by selectively destroying cells within the adrenal cortex. Analytical laboratories rely on this collection of high-quality reference standards to support rigorous pharmaceutical quality control and method validation. This category encompasses the active substance alongside its related impurities and metabolites, such as Hydroxy Mitotane and various dichlorodiphenyldichloroethane derivatives, which are essential for accurate impurity profiling and quantitative analysis. To further support precise regulatory compliance and sophisticated mass spectrometry applications, stable isotope labelled compounds, including deuterated and 13C-labelled variants, are available. These certified materials allow researchers to perform accurate system suitability testing, ensuring reliable identification and quantification of the drug and its breakdown products throughout the manufacturing and development lifecycle.